LogoLogo
OT PlatformOT GeneticsCommunityBlog
  • Open Targets Platform
  • Getting started
  • Target
    • Tractability
    • Safety
    • Chemical probes & TEPs
    • Baseline expression
    • Molecular interactions
    • Core Gene Essentiality
    • Pharmacogenetics
  • Disease or Phenotype
    • Clinical signs and symptoms
  • 🆕Variant
  • 🆕Study
  • Drug
    • Clinical Precedence
    • Pharmacovigilance
    • Pharmacogenetics
  • 🆕Credible Set
  • Target–disease evidence
  • Target–disease associations
  • 🆕GWAS & functional genomics
    • Data sources
    • Fine-mapping
    • Colocalisation
    • Locus-to-Gene (L2G)
    • Gentropy
  • Bibliography
  • Web interface
    • Associations on the Fly
    • Target Prioritisation
    • Evidence pages
    • Entity profile pages
  • Data and code access
    • Download datasets
    • Google BigQuery
    • GraphQL API
    • 🆕Platform infrastructure
    • 🆕Data pipeline
  • 🆕FAQs
  • Release notes
  • Citation
  • Licence
    • Terms of use
  • Partner Preview Platform
Powered by GitBook
On this page
  • Latest publication
  • Previous publications

Was this helpful?

Export as PDF

Citation

PreviousRelease notesNextLicence

Last updated 2 months ago

Was this helpful?

Latest publication

If you use the Open Targets Platform in your work, please cite our latest publication:

Buniello, A. et al. (2025). . Nucleic Acids Research.

Previous publications

We have additional publications about the Open Targets Platform:

  • Ochoa, D. et al. (2023). Nucleic Acids Research.

  • Ochoa, D. et al. (2021). . Nucleic Acids Research.

  • Carvalho-Silva, D. et al. (2019). . Nucleic Acids Research.

  • Koscielny, G. et al. (2017). . Nucleic Acids Research.

You can also refer to our publications about Open Targets Genetics and our Locus-to-Gene (L2G) pipeline:

  • Ghoussaini, M., et al. (2021) . Nucleic Acids Research.

  • Mountjoy, E., et al. (2021) . Nature Genetics.

Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery
The next-generation Open Targets Platform: reimagined, redesigned, rebuilt.
Open Targets Platform: supporting systematic drug–target identification and prioritisation
Open Targets Platform: new developments and updates two years on
Open Targets: a platform for therapeutic target identification and validation
Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics
An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci